Paediatric HIV symposium – 20th International AIDS Conference
Client: ViiV Healthcare
Consultant: Dr Gareth Tudor-Williams, Department of Medicine
Expertise: Anti-retroviral drugs, HIV infections/Paediatric HIV
Our consultants shared their expertise in anti-retroviral drugs, HIV infections/paediatric HIV to help ViiV Healthcare deliver symposia on growing the future leaders in paediatric HIV at the International Aids Conference 2014.
The Challenge
ViiV Healthcare is a pharmaceutical company that develop treatments for people with HIV. They needed help to deliver two symposia on paediatric HIV for AIDS 2014, the 20th International AIDS Conference, that aimed at mobilising stakeholders against an HIV epidemic.
The Solution
Dr Tudor-Williams has specialised in HIV infection in children since 1989 and has assisted in several initiatives to improve education and the administration of anti-retroviral drugs among HIV infected communities around the world.
He developed a symposium programme that educated delegates on the issues faced by children who have been living with HIV since birth, including slower drug development rates than for adults and community stigma. Additionally, the symposium discussed ways to identify, inspire and support the paediatric HIV leaders of tomorrow, particularly those who may be children currently living with the condition.
The Impact
The conference was attended by around 12,000 delegates and involved high profile speakers including Bill Clinton, Sir Bob Geldof and Executive Director of UNAIDS, Michel Sidibé. The symposium contributed to the overall aim of ‘stepping up the pace’ to ensure that HIV remains a top priority in the world today, focussing on improving HIV treatments and reducing stigma.
Dr Tudor-Williams comments:
I was honoured to contribute to this prestigious conference on a subject so closely aligned with my research and personal interests. Sharing my knowledge on paediatric HIV with the wider community through consultancy projects like this is essential to work towards real change for children living with HIV around the world. On a practical level, consultancy has allowed me to support my research in this area by funding staff development activities for my team such as meeting and conference attendance.
Dr Gareth Tudor-Williams
Department of Medicine, Imperial College London
Katy Hayward, Global Lead Paediatrics at ViiV Healthcare comments:
The conference was a great exercise to help to keep the idea of supporting tomorrow’s leaders in this field at the front of everyone’s mind. Basing our symposium on world class expertise undoubtedly strengthened our message and cause. Gareth’s professional approach and care has given hope that children living with HIV could be empowered in the future to significantly change the course of the HIV epidemic.
Katy Hayward
Global Lead Paediatrics, ViiV Healthcare
Share post:
Related case studies
Hepatitis C genotype and drug resistance testing
Genotype and resistance testing for new direct-acting antiviral (DAA) drugs designed to treat Hepatitis C virus (HCV). read more
Informing the debate on Britain’s electricity system
The electricity sector is currently undergoing unprecedented changes, including obligations to decarbonise and pressure to keep bills down. With old coal being driven off the system, new nuclear given the go-ahead, prices reaching new highs and lows, and clean energy overtaking fossil fuels for the first time, there is an increasing need for a strong evidence base and robust analysis. read more
Meta study-environmental impact of diamond mining
Skydiamonds commissioned a review of academic, industrial and grey literature on diamond production methods to provide them with a better understanding of the environmental impacts. read more